| Validation Study on the Removal of EpCAM-positive Tumour Cells From Blood Collected During Tumour Surgery Using Catumaxomab/Catuvab Device (NCT06789224) | Lindis Bloodcare GmbH | 2022-02-15 |
| A Study of Felmetatug Vedotin/SGN-B7H4V in Advanced Solid Tumors (NCT05194072) | Seagen, a wholly owned subsidiary of Pfizer | 2022-01-12 |
| A Study of ELI-002 in Subjects With KRAS Mutated Pancreatic Ductal Adenocarcinoma (PDAC) and Other Solid Tumors (NCT04853017) | Elicio Therapeutics | 2021-10-04 |
| Study of Irinotecan Liposome Injection in Patients With Advanced Biliary Tract Cancer (NCT05009953) | CSPC Ouyi Pharmaceutical Co., Ltd. | 2021-09-01 |
| A Dual Channel Supraglottic Airway Device (LMA Gastro) for Oxygenation in Patients Undergoing ERCP (NCT04740164) | M.D. Anderson Cancer Center | 2021-02-24 |
| Tucatinib Plus Trastuzumab and Oxaliplatin-based Chemotherapy or Pembrolizumab-containing Combinations for HER2+ Gastrointestinal Cancers (NCT04430738) | Seagen, a wholly owned subsidiary of Pfizer | 2020-09-15 |
| Target Therapy With GEMOX in Recectable Gallbladder Carcinoma Patients Monitored by ctDNA (NCT04183712) | Shanghai Jiao Tong University School of Medicine | 2020-06-01 |
| Apapitatin Combined With SOX for Palliative Adjuvant Chemotherapy in Patients With Advanced Gallbladder Carcinoma (NCT03702491) | Eastern Hepatobiliary Surgery Hospital | 2018-08-10 |
| Atezolizumab With or Without Cobimetinib in Treating Patients With Metastatic Bile Duct Cancer That Cannot Be Removed by Surgery or Gallbladder Cancer (NCT03201458) | National Cancer Institute (NCI) | 2018-02-08 |
| A Study of Circulating Exosome Proteomics In Gallbladder Carcinoma Patients (NCT03581435) | liu yingbin | 2018-01-01 |
| Comprehensive Genomic Profiling Combined With Real Life Data of "The German-Registry of Incidental Gallbladder Carcinoma" (NCT05222854) | Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest | 2017-10-11 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
| Unilateral Stenting Versus Bilateral Stenting for Malignant Hilar Biliary Obstruction (NCT02649712) | Xuzhou Central Hospital | 2016-01-20 |
| A Study of MEK162 With Gemcitabine and Oxaliplatin in Biliary Cancer (NCT02105350) | University Health Network, Toronto | 2015-06-01 |
| Genetic Analysis-Guided Dosing of FOLFIRABRAX in Treating Patients With Advanced Gastrointestinal Cancer (NCT02333188) | University of Chicago | 2014-12-01 |
| A Study of Different Dosing Schedules of Selumetinib With Cisplatin/Gemcitabine (CIS/GEM) Versus CIS/GEM Alone in Biliary Cancer (NCT02151084) | University Health Network, Toronto | 2014-11-01 |
| Clinical Trial to Investigate the Efficacy of Treatment With Gemcitabine/Pazopanib in Patients With Biliary Tree Cancer (NCT01855724) | Hellenic Cooperative Oncology Group | 2013-06-28 |
| Permission to Collect Blood Over Time for Research (NCT00767234) | Stanford University | 2008-08-01 |